ARTICLE | Clinical News
Therapeutic vaccine for genital herpes: Started 250-patient Phase II/III trial
August 9, 1993 7:00 AM UTC
Chiron Corp. (CHIR) Product: Therapeutic vaccine for genital herpes, consisting of gB2 and gD2 surface glycoproteins of HSV and MF59 adjuvant Indication: Frequent, severe genital herpes Status: Star...